Market Overview

Benzinga's Top Upgrades, Downgrades For August 3, 2020

Share:

Upgrades

  • Deutsche Bank upgraded the previous rating for Yum Brands Inc (NYSE: YUM) from Hold to Buy. In the second quarter, Yum Brands showed an EPS of $0.82, compared to $0.93 from the year-ago quarter. At the moment, the stock has a 52-week-high of $119.72 and a 52-week-low of $54.95. Yum Brands closed at $91.15 at the end of the last trading period.
  • Bernstein upgraded the previous rating for Qualcomm Inc (NASDAQ: QCOM) from Market Perform to Outperform. In the third quarter, Qualcomm showed an EPS of $0.86, compared to $0.80 from the year-ago quarter. The stock has a 52-week-high of $107.75 and a 52-week-low of $58.00. At the end of the last trading period, Qualcomm closed at $105.61.
  • According to Stifel, the prior rating for Covanta Holding Corp (NYSE: CVA) was changed from Hold to Buy. For the second quarter, Covanta Holding had an EPS of ($0.10), compared to year-ago quarter EPS of ($0.16). The current stock performance of Covanta Holding shows a 52-week-high of $17.97 and a 52-week-low of $6.57. Moreover, at the end of the last trading period, the closing price was at $9.83.
  • For Expedia Group Inc (NASDAQ: EXPE), BTIG upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Expedia Group showed an EPS of ($4.09), compared to $1.77 from the year-ago quarter. The stock has a 52-week-high of $139.88 and a 52-week-low of $40.76. At the end of the last trading period, Expedia Group closed at $81.01.
  • For Nabors Industries Ltd (NYSE: NBR), Barclays upgraded the previous rating of Underweight to the current rating Equal-Weight. In the second quarter, Nabors Industries showed an EPS of ($14.45), compared to ($0.41) from the year-ago quarter. The current stock performance of Nabors Industries shows a 52-week-high of $87.00 and a 52-week-low of $0.20. Moreover, at the end of the last trading period, the closing price was at $42.52.
  • According to B of A Securities, the prior rating for Floor & Decor Holdings Inc (NYSE: FND) was changed from Neutral to Buy. Floor & Decor Hldgs earned $0.13 in the second quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $71.72 and a 52-week-low of $24.36. Floor & Decor Hldgs closed at $65.89 at the end of the last trading period.
  • According to UBS, the prior rating for Pinterest Inc (NYSE: PINS) was changed from Neutral to Buy. For the second quarter, Pinterest had an EPS of ($0.07), compared to year-ago quarter EPS of ($0.06). The stock has a 52-week-high of $36.83 and a 52-week-low of $10.10. At the end of the last trading period, Pinterest closed at $34.29.
  • For Merck & Co Inc (NYSE: MRK), Goldman Sachs upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Merck & Co showed an EPS of $1.37, compared to $1.30 from the year-ago quarter. The current stock performance of Merck & Co shows a 52-week-high of $92.64 and a 52-week-low of $65.25. Moreover, at the end of the last trading period, the closing price was at $80.24.
  • According to JP Morgan, the prior rating for Kansas City Southern (NYSE: KSU) was changed from Underweight to Neutral. In the second quarter, Kansas City Southern showed an EPS of $1.15, compared to $1.64 from the year-ago quarter. The current stock performance of Kansas City Southern shows a 52-week-high of $184.16 and a 52-week-low of $92.86. Moreover, at the end of the last trading period, the closing price was at $171.82.
  • For Pinterest Inc (NYSE: PINS), Pivotal Research upgraded the previous rating of Hold to the current rating Buy. Pinterest earned ($0.07) in the second quarter, compared to ($0.06) in the year-ago quarter. The current stock performance of Pinterest shows a 52-week-high of $36.83 and a 52-week-low of $10.10. Moreover, at the end of the last trading period, the closing price was at $34.29.
  • JP Morgan upgraded the previous rating for Minerals Technologies Inc (NYSE: MTX) from Neutral to Overweight. Minerals Technologies earned $0.85 in the second quarter, compared to $1.11 in the year-ago quarter. The stock has a 52-week-high of $59.18 and a 52-week-low of $27.28. At the end of the last trading period, Minerals Technologies closed at $46.76.
  • For Varian Medical Systems Inc (NYSE: VAR), Evercore ISI Group upgraded the previous rating of Underperform to the current rating In-Line. Varian Medical Systems earned $0.78 in the third quarter, compared to $1.32 in the year-ago quarter. The stock has a 52-week-high of $150.06 and a 52-week-low of $89.62. At the end of the last trading period, Varian Medical Systems closed at $142.71.
  • According to Evercore ISI Group, the prior rating for MoneyGram International Inc (NASDAQ: MGI) was changed from Underperform to In-Line. In the second quarter, MoneyGram showed an EPS of $0.01, compared to $0.12 from the year-ago quarter. At the moment, the stock has a 52-week-high of $6.70 and a 52-week-low of $1.15. MoneyGram closed at $3.48 at the end of the last trading period.

 

Downgrades

  • For Weyerhaeuser Co (NYSE: WY), DA Davidson downgraded the previous rating of Buy to the current rating Neutral. For the second quarter, Weyerhaeuser had an EPS of $0.11, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $31.58 and a 52-week-low of $13.10. At the end of the last trading period, Weyerhaeuser closed at $27.79.
  • According to Raymond James, the prior rating for Omega Healthcare Investors Inc (NYSE: OHI) was changed from Strong Buy to Outperform. In the first quarter, Omega Healthcare showed an EPS of $0.79, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $45.22 and a 52-week-low of $13.33. At the end of the last trading period, Omega Healthcare closed at $32.37.
  • For Macrogenics Inc (NASDAQ: MGNX), Citigroup downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Macrogenics showed an EPS of ($0.94), compared to ($0.65) from the year-ago quarter. The current stock performance of Macrogenics shows a 52-week-high of $32.18 and a 52-week-low of $4.04. Moreover, at the end of the last trading period, the closing price was at $25.40.
  • According to Wells Fargo, the prior rating for WEX Inc (NYSE: WEX) was changed from Overweight to Equal-Weight. WEX earned $1.21 in the second quarter, compared to $2.28 in the year-ago quarter. The current stock performance of WEX shows a 52-week-high of $236.51 and a 52-week-low of $71.12. Moreover, at the end of the last trading period, the closing price was at $158.25.
  • For Helmerich & Payne Inc (NYSE: HP), Barclays downgraded the previous rating of Equal-Weight to the current rating Underweight. For the third quarter, Helmerich & Payne had an EPS of ($0.34), compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $50.34 and a 52-week-low of $12.40. Helmerich & Payne closed at $17.83 at the end of the last trading period.
  • Stephens & Co. downgraded the previous rating for DuPont de Nemours Inc (NYSE: DD) from Overweight to Equal-Weight. For the second quarter, DuPont de Nemours had an EPS of $0.70, compared to year-ago quarter EPS of $0.97. The current stock performance of DuPont de Nemours shows a 52-week-high of $73.80 and a 52-week-low of $28.33. Moreover, at the end of the last trading period, the closing price was at $53.49.

 

Initiations

  • Stifel initiated coverage on Geron Corp (NASDAQ: GERN) with a Buy rating. For the first quarter, Geron had an EPS of ($0.08), compared to year-ago quarter EPS of ($0.05). The current stock performance of Geron shows a 52-week-high of $2.40 and a 52-week-low of $0.75. Moreover, at the end of the last trading period, the closing price was at $1.59.
  • HC Wainwright & Co. initiated coverage on ORIC Pharmaceuticals Inc (NASDAQ: ORIC) with a Buy rating. The price target for ORIC Pharmaceuticals is set to $52.00. The current stock performance of ORIC Pharmaceuticals shows a 52-week-high of $40.67 and a 52-week-low of $19.85. Moreover, at the end of the last trading period, the closing price was at $20.07.
  • With a current rating of Buy, HC Wainwright & Co. initiated coverage on Mirum Pharmaceuticals Inc (NASDAQ: MIRM). The price target seems to have been set at $52.00 for Mirum Pharmaceuticals. Mirum Pharmaceuticals earned ($0.86) in the first quarter. The current stock performance of Mirum Pharmaceuticals shows a 52-week-high of $28.31 and a 52-week-low of $6.51. Moreover, at the end of the last trading period, the closing price was at $22.08.
  • Piper Sandler initiated coverage on NGM Biopharmaceuticals Inc (NASDAQ: NGM) with an Overweight rating. The price target for NGM Biopharmaceuticals is set to $30.00. In the first quarter, NGM Biopharmaceuticals showed an EPS of ($0.28), compared to ($1.21) from the year-ago quarter. The stock has a 52-week-high of $23.95 and a 52-week-low of $8.81. At the end of the last trading period, NGM Biopharmaceuticals closed at $18.29.
 

Related Articles (CVA + DD)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
JBLRBC CapitalMaintains38.0
COSTRBC CapitalMaintains412.0
COSTMKM PartnersMaintains325.0
NOWStifelMaintains500.0
MTNTruist SecuritiesMaintains243.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com